AbbVie’s tavapadon, an investigational oral once-daily dopamine D1/D5 partial agonist, is nearing a potential regulatory submission, bolstered by new post-hoc…
Read More

AbbVie’s tavapadon, an investigational oral once-daily dopamine D1/D5 partial agonist, is nearing a potential regulatory submission, bolstered by new post-hoc…
Read More
Since its inception in 1921, Science News has stood as a steadfast beacon of independent, nonprofit journalism, dedicated to delivering…
Read More
The landscape of artificial intelligence is undergoing a significant transformation, moving beyond mere conversational interfaces to sophisticated, actionable agent systems.…
Read More
In a groundbreaking discovery that sheds new light on the astonishing pace at which life can diversify, researchers have identified…
Read More
In a recent clinical update on the "This Week in Virology" (TWiV) podcast, Dr. Daniel Griffin and host Vincent Racaniello…
Read More
OZMOSI and Planview have announced a significant partnership aimed at transforming how pharmaceutical organizations approach research and development (R&D) planning.…
Read More
Beneath the seemingly ordinary farmland of New South Wales’ central tablelands lies a geological marvel that is reshaping our understanding…
Read More
This Week in Virology (TWiV) episode 1287, released on January 11, 2026, delved into two significant areas of viral research:…
Read More
The foundational fabric of our universe is governed by a set of fundamental constants, immutable values that dictate the behavior…
Read More
The universe, a vast expanse governed by fundamental forces and teeming with elusive particles, has once again presented physicists with…
Read More